Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by FREEDOM55on Jan 06, 2021 2:28pm
241 Views
Post# 32234630

INFO

INFO

Ontario launches COVID-19 testing program at Toronto Pearson airport

Alicja Siekierska
·1 min read
 
 

Ontario is launching a pilot program at Toronto’s Pearson International Airport that will see travellers tested upon arrival, voluntarily and for free.

Starting Wednesday, eligible passengers arriving at the airport will be able to get a free, self-collected PCR swab test, supervised by a health care provider. Test results will be provided to Ontario’s Lab Information System within 48-hours, and local public health authorities will follow-up on positive test results.

Ontario Premier Doug Ford called the pilot project “a game changer.”

“With over 60,000 international passengers coming into Pearson airport every week, we can’t take any unnecessary risks,” Ford said in a statement Wednesday.

“That’s why we’re putting in place this new pilot program to help stop the spread of COVID-19 and respond to new threats like the recent strain of the virus we’re seeing in an alarming number of countries without the same travel restrictions as the U.K.”

All international travellers will still have to follow the federal government’s 14-day mandatory quarantine, even if they receive a negative test result. However, the province said the next stage of the project will introduce a modified quarantine for passengers who test negative.

Ford had previously lashed out at the federal government, urging it to move faster on COVID-19 testing for international travellers. He compared the way the border was being managed to a leaky roof.

“Let’s get the testing at the airport and stop the leak,” he said in December.

More to come.


<< Previous
Bullboard Posts
Next >>